Glazer Capital’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-21,990
Closed -$216K – 947
2021
Q3
$216K Buy
+21,990
New +$217K ﹤0.01% 667

Other funds holding DALS

Glazer Capital's DALS Position: Q4 2021 in Review

Glazer Capital sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q4 2021, closing a stake of 21,990 shares — an estimated $216K sold.

Glazer Capital first reported a position in DALS in Q3 2021 and held it in 1 quarter. The position peaked at $216K in Q3 2021. 36 funds tracked by Wall St. Rank hold DALS as of Q4 2021.

  • Glazer Capital reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q4 2021 after selling out during the quarter.
  • Glazer Capital sold 21,990 DA32 Life Science Tech Acquisition Corp shares in Q4 2021, an estimated $216K.
  • Glazer Capital first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 1 quarter.
  • Glazer Capital's DA32 Life Science Tech Acquisition Corp position peaked at $216K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q4 2021.

Based on Glazer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.